Highlights
The global High Throughput Screening (HTS) Service market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for High Throughput Screening (HTS) Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for High Throughput Screening (HTS) Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for High Throughput Screening (HTS) Service in Pharmaceutical Industry is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of High Throughput Screening (HTS) Service include Charles River Laboratories, BOC Sciences, Creative BioMart, Creative Biostructure, AntalGenics, Bienta/Enamine, CIBIO HTS and Validation core facility, Domainex and Creative Diagnostics, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for High Throughput Screening (HTS) Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High Throughput Screening (HTS) Service.
The High Throughput Screening (HTS) Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global High Throughput Screening (HTS) Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the High Throughput Screening (HTS) Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Charles River Laboratories
BOC Sciences
Creative BioMart
Creative Biostructure
AntalGenics
Bienta/Enamine
CIBIO HTS and Validation core facility
Domainex
Creative Diagnostics
Axcelead
Selvita
Segment by Type
High-content Screening
High-throughput Screening
siRNA Screening
RNAi Screening
Phenotypic Screening
Segment by Application
Pharmaceutical Industry
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High Throughput Screening (HTS) Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High Throughput Screening (HTS) Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 High-content Screening
1.2.3 High-throughput Screening
1.2.4 siRNA Screening
1.2.5 RNAi Screening
1.2.6 Phenotypic Screening
1.3 Market by Application
1.3.1 Global High Throughput Screening (HTS) Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Industry
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global High Throughput Screening (HTS) Service Market Perspective (2018-2029)
2.2 High Throughput Screening (HTS) Service Growth Trends by Region
2.2.1 Global High Throughput Screening (HTS) Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 High Throughput Screening (HTS) Service Historic Market Size by Region (2018-2023)
2.2.3 High Throughput Screening (HTS) Service Forecasted Market Size by Region (2024-2029)
2.3 High Throughput Screening (HTS) Service Market Dynamics
2.3.1 High Throughput Screening (HTS) Service Industry Trends
2.3.2 High Throughput Screening (HTS) Service Market Drivers
2.3.3 High Throughput Screening (HTS) Service Market Challenges
2.3.4 High Throughput Screening (HTS) Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High Throughput Screening (HTS) Service Players by Revenue
3.1.1 Global Top High Throughput Screening (HTS) Service Players by Revenue (2018-2023)
3.1.2 Global High Throughput Screening (HTS) Service Revenue Market Share by Players (2018-2023)
3.2 Global High Throughput Screening (HTS) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by High Throughput Screening (HTS) Service Revenue
3.4 Global High Throughput Screening (HTS) Service Market Concentration Ratio
3.4.1 Global High Throughput Screening (HTS) Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High Throughput Screening (HTS) Service Revenue in 2022
3.5 High Throughput Screening (HTS) Service Key Players Head office and Area Served
3.6 Key Players High Throughput Screening (HTS) Service Product Solution and Service
3.7 Date of Enter into High Throughput Screening (HTS) Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 High Throughput Screening (HTS) Service Breakdown Data by Type
4.1 Global High Throughput Screening (HTS) Service Historic Market Size by Type (2018-2023)
4.2 Global High Throughput Screening (HTS) Service Forecasted Market Size by Type (2024-2029)
5 High Throughput Screening (HTS) Service Breakdown Data by Application
5.1 Global High Throughput Screening (HTS) Service Historic Market Size by Application (2018-2023)
5.2 Global High Throughput Screening (HTS) Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America High Throughput Screening (HTS) Service Market Size (2018-2029)
6.2 North America High Throughput Screening (HTS) Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America High Throughput Screening (HTS) Service Market Size by Country (2018-2023)
6.4 North America High Throughput Screening (HTS) Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High Throughput Screening (HTS) Service Market Size (2018-2029)
7.2 Europe High Throughput Screening (HTS) Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe High Throughput Screening (HTS) Service Market Size by Country (2018-2023)
7.4 Europe High Throughput Screening (HTS) Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific High Throughput Screening (HTS) Service Market Size (2018-2029)
8.2 Asia-Pacific High Throughput Screening (HTS) Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific High Throughput Screening (HTS) Service Market Size by Region (2018-2023)
8.4 Asia-Pacific High Throughput Screening (HTS) Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America High Throughput Screening (HTS) Service Market Size (2018-2029)
9.2 Latin America High Throughput Screening (HTS) Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America High Throughput Screening (HTS) Service Market Size by Country (2018-2023)
9.4 Latin America High Throughput Screening (HTS) Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High Throughput Screening (HTS) Service Market Size (2018-2029)
10.2 Middle East & Africa High Throughput Screening (HTS) Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa High Throughput Screening (HTS) Service Market Size by Country (2018-2023)
10.4 Middle East & Africa High Throughput Screening (HTS) Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories High Throughput Screening (HTS) Service Introduction
11.1.4 Charles River Laboratories Revenue in High Throughput Screening (HTS) Service Business (2018-2023)
11.1.5 Charles River Laboratories Recent Development
11.2 BOC Sciences
11.2.1 BOC Sciences Company Detail
11.2.2 BOC Sciences Business Overview
11.2.3 BOC Sciences High Throughput Screening (HTS) Service Introduction
11.2.4 BOC Sciences Revenue in High Throughput Screening (HTS) Service Business (2018-2023)
11.2.5 BOC Sciences Recent Development
11.3 Creative BioMart
11.3.1 Creative BioMart Company Detail
11.3.2 Creative BioMart Business Overview
11.3.3 Creative BioMart High Throughput Screening (HTS) Service Introduction
11.3.4 Creative BioMart Revenue in High Throughput Screening (HTS) Service Business (2018-2023)
11.3.5 Creative BioMart Recent Development
11.4 Creative Biostructure
11.4.1 Creative Biostructure Company Detail
11.4.2 Creative Biostructure Business Overview
11.4.3 Creative Biostructure High Throughput Screening (HTS) Service Introduction
11.4.4 Creative Biostructure Revenue in High Throughput Screening (HTS) Service Business (2018-2023)
11.4.5 Creative Biostructure Recent Development
11.5 AntalGenics
11.5.1 AntalGenics Company Detail
11.5.2 AntalGenics Business Overview
11.5.3 AntalGenics High Throughput Screening (HTS) Service Introduction
11.5.4 AntalGenics Revenue in High Throughput Screening (HTS) Service Business (2018-2023)
11.5.5 AntalGenics Recent Development
11.6 Bienta/Enamine
11.6.1 Bienta/Enamine Company Detail
11.6.2 Bienta/Enamine Business Overview
11.6.3 Bienta/Enamine High Throughput Screening (HTS) Service Introduction
11.6.4 Bienta/Enamine Revenue in High Throughput Screening (HTS) Service Business (2018-2023)
11.6.5 Bienta/Enamine Recent Development
11.7 CIBIO HTS and Validation core facility
11.7.1 CIBIO HTS and Validation core facility Company Detail
11.7.2 CIBIO HTS and Validation core facility Business Overview
11.7.3 CIBIO HTS and Validation core facility High Throughput Screening (HTS) Service Introduction
11.7.4 CIBIO HTS and Validation core facility Revenue in High Throughput Screening (HTS) Service Business (2018-2023)
11.7.5 CIBIO HTS and Validation core facility Recent Development
11.8 Domainex
11.8.1 Domainex Company Detail
11.8.2 Domainex Business Overview
11.8.3 Domainex High Throughput Screening (HTS) Service Introduction
11.8.4 Domainex Revenue in High Throughput Screening (HTS) Service Business (2018-2023)
11.8.5 Domainex Recent Development
11.9 Creative Diagnostics
11.9.1 Creative Diagnostics Company Detail
11.9.2 Creative Diagnostics Business Overview
11.9.3 Creative Diagnostics High Throughput Screening (HTS) Service Introduction
11.9.4 Creative Diagnostics Revenue in High Throughput Screening (HTS) Service Business (2018-2023)
11.9.5 Creative Diagnostics Recent Development
11.10 Axcelead
11.10.1 Axcelead Company Detail
11.10.2 Axcelead Business Overview
11.10.3 Axcelead High Throughput Screening (HTS) Service Introduction
11.10.4 Axcelead Revenue in High Throughput Screening (HTS) Service Business (2018-2023)
11.10.5 Axcelead Recent Development
11.11 Selvita
11.11.1 Selvita Company Detail
11.11.2 Selvita Business Overview
11.11.3 Selvita High Throughput Screening (HTS) Service Introduction
11.11.4 Selvita Revenue in High Throughput Screening (HTS) Service Business (2018-2023)
11.11.5 Selvita Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Charles River Laboratories
BOC Sciences
Creative BioMart
Creative Biostructure
AntalGenics
Bienta/Enamine
CIBIO HTS and Validation core facility
Domainex
Creative Diagnostics
Axcelead
Selvita
*If Applicable.